GENVOYA identity
The active ingredient recorded for this profile is Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide. Confirm the prescribed brand or ingredient before comparing packages.
Specialty Care medication reference
GENVOYA price reference.
GENVOYA (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide) has 1 European package reference in this catalog. The listed 150 mg/150 mg/200 mg/10 mg film-coated tablets · 3 × 30 tablets reference is €3,547.47. 1 package reference also includes recorded U.S. cash-price context ($12,984.38); compare only like-for-like strength, form and quantity. Figures are informational, not a quote or supply guarantee.
Estimated medicine cost range€3,547.47
Source-supported U.S. cash context$12,984.38
Estimated price differenceup to €7,812.37
Last recorded source review
Reference profile
Clear information.
Case-specific review.
The listed 150 mg/150 mg/200 mg/10 mg film-coated tablets · 3 × 30 tablets reference is €3,547.47. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.
Package-level price scope
The listed 150 mg/150 mg/200 mg/10 mg film-coated tablets · 3 × 30 tablets reference is €3,547.47. Strength, dosage form and quantity can materially change a like-for-like comparison.
Comparison evidence
1 package reference also includes recorded U.S. cash-price context ($12,984.38); compare only like-for-like strength, form and quantity.
Package references
GENVOYA listed formats
European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.
| Package reference | Estimated medicine cost reference | Comparable U.S. cash reference | Estimated difference | Source notes | Select |
|---|---|---|---|---|---|
| 150 mg/150 mg/200 mg/10 mg film-coated tablets · 3 × 30 tablets Gilead Sciences GmbH · PZN 11531120 | €3,547.47 | $12,984.38 | €7,812.37 | Imported legacy U.S. cash comparison; source package figure $4327.99; external source URL not recorded in the source workbook Recorded review: | Request this package |
Data scopeReference information, not a quote
Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.
How the references are preparedSources and editorial responsibility
Where this GENVOYA reference comes from
US Med Access publishes this page as an independent reference-information provider. Package records are retained with their available source notes and review dates; missing provenance is stated rather than inferred.
- Publisher and author
- US Med Access editorial team
- Recorded source review
- Reference scope
- 1 active European package record with supported U.S. cash-price context where listed
Frequently asked questions
GENVOYA price and package questions
Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.
01What is the listed GENVOYA price in Europe?
This catalog lists one European package reference at €3,547.47: 150 mg/150 mg/200 mg/10 mg film-coated tablets · 3 × 30 tablets. It is a dated information reference, not a live quote or sale offer.
02How does the GENVOYA European reference compare with U.S. cash prices?
Recorded U.S. cash-price context is $12,984.38 across 1 supported package reference. A comparison is meaningful only where strength, form and quantity are equivalent; source notes identify normalization or limitations.
03Are the listed GENVOYA amounts a quote or sale offer?
No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.
04How do I request the correct GENVOYA package?
Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.
Availability and logistics
Need a package-level review?
Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.